Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress

被引:147
|
作者
Milne, Ginger L. [1 ]
Yin, Huiyong [1 ]
Brooks, Joshua D. [1 ]
Sanchez, Stephanie [1 ]
Roberts, L. Jackson, II [1 ]
Morrow, Jason D. [1 ]
机构
[1] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA
关键词
D O I
10.1016/S0076-6879(07)33006-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Oxidant stress has been implicated in a wide variety of disease processes. One method to quantify oxidative injury is to measure lipid peroxidation. Quantification of a group of prostaglandin F-2-like compounds derived from the nonezymatic oxidation of arachidonic acid, termed the F-2-isoprostanes (F-2-IsoPs), provides an accurate assessment of oxidative stress both in vitro and in vivo. In fact, in a recent National Institutes of Health-sponsored independent study, F2-IsoPs were shown to be the most reliable index of in vivo oxidant stress when compared against other well-known biomarkers. This article summarizes current methodology used to quantify these molecules. Our laboratory's method to measure F2-IsoPs in biological fluids and tissues using gas chromatography-mass spectrometry is detailed herein. In addition, other mass spectrometric approaches, as well as immunological methods to measure these compounds, are discussed. Finally, the utility of these molecules as in vivo biomarkers of oxidative stress is summarized.
引用
收藏
页码:113 / 126
页数:14
相关论文
共 50 条
  • [21] F2-isoprostanes:: Review of analytical methods
    Berdeaux, O
    Scruel, O
    Cracowski, JL
    Durand, T
    CURRENT PHARMACEUTICAL ANALYSIS, 2006, 2 (01) : 69 - 78
  • [22] F2-Isoprostanes and Adiposity in Older Adults
    Kanayk, Alka M.
    Wassel, Christina L.
    Harris, Tamara
    Cummings, Steven R.
    Kritchevsky, Steve
    Goodpaster, Bret
    Satter-Field, Suzanne
    Gross, Myron
    DIABETES, 2009, 58 : A256 - A256
  • [23] Elevated F2-isoprostanes in thalassemic patients
    Matayatsuk, Chutima
    Lee, Chung-Yung J.
    Kalpravidh, Ruchaneekorn W.
    Sirankapracha, Pornpan
    Wilairat, Prapin
    Fucharoen, Suthat
    Halliwell, Barry
    FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (12) : 1649 - 1655
  • [24] Urinary F2-isoprostanes and the risk of hypertension
    Melton, Charles David
    Luo, Ruiyan
    Wong, Brett J.
    Spasojevic, Ivan
    Wagenknecht, Lynne E.
    D'Agostino, Ralph B., Jr.
    Il'yasova, Dora
    ANNALS OF EPIDEMIOLOGY, 2017, 27 (06) : 391 - 396
  • [25] The isoprostanes: Their quantification as an index of oxidant stress status in vivo
    Morrow, JD
    DRUG METABOLISM REVIEWS, 2000, 32 (3-4) : 377 - 385
  • [26] EFFECT OF VITAMIN E AND SELENIUM ON F2-ISOPROSTANES, AN OXIDATIVE STRESS BIOMARKER
    Guertin, K. A.
    Grant, R. K.
    Kristal, A. R.
    Arnold, K. B.
    Hartline, J. A.
    Goodman, P. J.
    Tangen, C. M.
    Minasian, L. M.
    Lippman, S. M.
    Klein, E.
    Cassano, P. A.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S324 - S324
  • [27] Measurement of F2-isoprostanes unveils profound oxidative stress in aged rats
    Roberts, LJ
    Reckelhoff, JF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (01) : 254 - 256
  • [28] Urinary F2-isoprostanes formation in kidney transplantation
    Cracowski, JL
    Souvignet, C
    Quirin, N
    Grosbois, X
    Bayle, F
    Stanke-Labesque, F
    Vialtel, P
    Bessard, G
    CLINICAL TRANSPLANTATION, 2001, 15 (01) : 58 - 62
  • [29] The large-scale measurement of F2-isoprostanes
    Gross, Myron D.
    Lewis, Linda
    Hayes, Jennifer
    FASEB JOURNAL, 2007, 21 (06): : A1093 - A1093
  • [30] F2-isoprostanes are not just markers of oxidative stresse
    Comporti, Mario
    Signorini, Cinzia
    Arezzini, Beatrice
    Vecchio, Daniela
    Monaco, Barbara
    Gardi, Concetta
    FREE RADICAL BIOLOGY AND MEDICINE, 2008, 44 (03) : 247 - 256